With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.7787-70-4,Copper(I) bromide,as a common compound, the synthetic route is as follows.
7787-70-4, General procedure: A suspension of copper(I) iodide (0.190 g, 1.0 mmol) and dppc (0.534 g, 1.0 mmol) in20 mL of CH2Cl2 was stirred for 6 h at room temperature to form a light-yellow precipitate.The precipitate was filtered off and purified by recrystallization from CH2Cl2/ethanolto give yellow crystals (Yield: 0.618 g, 85.3%).
The synthetic route of 7787-70-4 has been constantly updated, and we look forward to future research findings.
Reference£º
Article; Li, Qian; Wei, Qiong; Xie, Pei; Liu, Li; Zhong, Xin-Xin; Li, Fa-Bao; Zhu, Nian-Yong; Wong, Wai-Yeung; Chan, Wesley Ting-Kwok; Qin, Hai-Mei; Alharbi, Njud S.; Journal of Coordination Chemistry; vol. 71; 24; (2018); p. 4072 – 4085;,
Copper catalysis in organic synthesis – NCBI
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”